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MENORRHAGIA IN CLINICAL MEDICINE
Excessive menstrual bleeding—menorrhagia is a common gynecologic disorder affecting women
of reproductive age. Subjectively, menorrhagia is defined as a complaint of heavy cyclical
menstrual bleeding occurring over several consecutive cycles (Rönnerdag and Odlind, 1999).
Objectively, it can be defined as heavy menstrual bleeding lasting for more than 7 days or
resulting in the loss of more than 80 mL per menstrual cycle (ACOG Committee on Practice
Bulletins—Gynecology, American College of Obstetricians and Gynecologists, 2001). An objective
evaluation of the existence of menorrhagia is not simple. Alkaline hematin technique is completely
objective measure (extracting hemoglobin from sanitary wear to assess blood loss), but it is
impractical out of controlled research settings. Widely used alternative is the pictorial blood
loss assessment chart (PBAC) and this is semiobjective method takes into account the number
and the degree of staining of items of sanitary wear used. PBAC is easier to perform than the
alkaline hematin technique, yet yields more objective results than self-reporting (Warner et al.,
2004). Data from literature suggested that approximately 10% of reproductive-aged women had
objective evidence of menorrhagia, but studies based on self-reported information suggested
that approximately 30% of women of reproductive age were aﬄicted with heavy menstrual
bleeding (Dilley et al., 2002; Shapley et al., 2004). According to our research, out of 115 women
who self-report these excessive menstrual bleeding only 55% had actually verified menorrhagia
by PBAC (Djukic et al., 2013). Menorrhagia can happen due to anatomic (uterine fibroids,
endometrial polyps, endometrial hyperplasia, and pregnancy), endocrinologic (thyroid and adrenal
gland dysfunction, pituitary tumors, anovulatory cycles, polycystic ovarial syndrome, obesity, and
vasculature imbalance), iatrogenic (steroid hormones, chemotherapy agents, medications) and
organic (organ dysfunction infection, bleeding disorders) abnormality (Vilos et al., 2001; Albers
et al., 2004).
THE ROLE OF BLEEDING DISORDERS
Underlying bleeding disorders only have been recognized during the last two decades as a
significant etiopathogenetic factor for menorrhagia formation. The available data from the
literature show the frequency of hemostasis disorders in women with menorrhagia in the range
of 10–20% (El-Hemaidi et al., 2007), whereas some of the most representative studies by Kadir and
associates state the information about 17% of patients (Kadir et al., 1998). The reported prevalence
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of von Willebrands Disease (vWD) as the most frequent among
them is ranging from 5 to 20% with an overall estimate of
13%, based on a systematic review (Shankar et al., 2004). The
considerable proportion of women with menorrhagia is found
to have single coagulation factor deficiencies such as factor XI
deficiency (1–4%), carriers of hemophilia A and hemophilia B
observed in approximately 1–4% of females with menorrhagia
and less common deficiencies of factor I, II, V, VII, X, XI, XIII
(Dilley et al., 2001; Mannucci et al., 2004; Philipp et al., 2005; Plug
et al., 2006).
Previous research has shown that in the population of women
who suffer from menorrhagia, the frequency of disorders of
hemostasis is 17% (Djukic et al., 2009). Analyzing the incidence
of certain disorders of hemostasis in previous research is shown
that the most commonly disorder is also VWD, although
deficiency of factor IX, then deficiencies of factor FVII, X, and
XI (Djukic et al., 2013) (Figure 1).
Studies have shown that physicians are not likely to consider
a bleeding disorder as a possible cause of menorrhagia.
Only 3% of them would refer patients to a specialist and
four percent of gynecologists surveyed would consider von
Willebrand’s disease as a possible diagnosis in women with
menorrhagia (Dilley et al., 2002). Anamnestic indicators
suggesting an underlying bleeding disorder include menorrhagia
since menarche, failed response to conventional management
of menorrhagia or family history of a bleeding disorder. In
addition, the clinical presentation includes: epistaxis, bleeding
of oral cavity or gastrointestinal tract without an obvious
anatomic lesion, notable bruising without injury; minor wound
bleeding, prolonged or excessive bleeding after dental extraction,
unexpected postsurgical bleeding, hemorrhage from ovarian
cysts or corpus luteum; hemorrhage requiring blood transfusion;
postpartum hemorrhage (especially delayed) (Nicols et al., 2008;
FIGURE 1 | Frequency of coagulation disorders in Serbian women with symptoms of menorrhagia. vWD, von Willebrand disease; FVII, factor VII deficiency
VII; FIX, factor IX deficiency; FX, factor X deficiency; FXI, factor XI deficiency.
Rodeghiero et al., 2009). In a population of women who suffer
from heavy menstrual bleeding, disorders of hemostasis are
often not recognized. Some studies show that the diagnostic
delay from onset of bleeding symptoms can be up to 16
years (Kirtava et al., 2004). As these patients usually do not
respond adequately to conventional treatment for menorrhagia,
the radical procedures (like a hysterectomy) carry out more
often than is necessary. Referral to an attending gynecologist
for menorrhagia meant a 43% chance of a hysterectomy
(Coulter et al., 1991) and menorrhagia is the major cause
for approximately 300,000 hysterectomies per year in the
U.S (James et al., 2006). Studies have shown that women
with von Willebrand’s disease are more likely to undergo a
hysterectomy and to have the hysterectomy at a younger age
(Kirtava et al., 2003). A randomized comparison of approach
with hysterectomy and the levonorgestrel-releasing intrauterine
system (IUS) in terms of the quality of life of women with
menorrhagia and cost-effectiveness demonstrated that health-
related quality of life improved significantly in both the IUS
and hysterectomy, but overall costs were about three times
higher for the hysterectomy group (Hurskainen et al., 2001).
Timely diagnosis and treatment of hemostasis disorders in
women with menorrhagia, unnecessary hysterectomy could be
avoided. Undiagnosed coagulation abnormalities have effect on
women’s quality of life. It can cause serious problems such as
iron deficiency anemia, complications from surgical procedures,
lost work or school time, lifestyle issues, psychological problems
(Rae et al., 2013). Anemia is associated with menorrhagia and
coagulation abnormalities in women of reproductive age. At
least 20 % of women with heavy menstrual bleeding experience
anemia (Vercellini et al., 1993). In the local European study of 115
women who reported menorrhagia 53% suffered from anemia
(Djukic et al., 2011).
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EXCESSIVE HYSTERECTOMY AND
OPPORTUNITY COSTS OF BLEEDING
DISORDERS MEDICAL CARE
Disorders of hemostasis, especially the ones seldom recognized
(Lukes et al., 2005), have a major impact on health-related quality
of life, work impairment and health-care costs. So far published
data indicate that this field of clinical medicine accounts for a
large share of workload for the national health systems, hospital
sector and primary care alike (Fraser et al., 2009). Global Burden
of Disease Project reports scale of morbidity, mortality (Wang
et al., 2016) and disability attributable to this group of illnesses
to a great detail (Vos et al., 2016). Associated workload and
economic burden of abnormal uterine bleeding was proved to be
significant even in highly effective health sectors. The national
health expenditure available and current resource allocation
strategy varies greatly with mature Western (Jakovljevic, 2016)
and top performing health markets representing different
historical legacies (Jakovljevic et al., 2016a). However, regardless
of these large geographical diversity, willingness to pay threshold
in bleeding disorders remains an issue for public debate in
many countries (Eastaugh, 2000). In case of hemophilia and Von
Willebrand’s illness as the most frequent conditions, thorough
studies on cost-effective procedures are available (Miners et al.,
1998). Due to bold pharmaceutical innovation in this area a
variety of drugs have been evaluated as well (Goudemand, 1999).
However, particularly concerning interventions are presented
by the surgical procedures that might have been avoided.
Once performed, hysterectomia in women of child bearing
age, in the Era of low fertility, (Jakovljevic and Laaser, 2015)
could mean a life time decision affecting family planning and
core life goals (Cloutier-Steele and West, 2003; Sardeshpande,
2014).
Certain lack of awareness of the potential of hemostasis
disorders to cause abnormal bleeding is clearly present in
the clinical gynecology. Besides there is a substantial need to
develop more reliable clinical tools for the objective assessment
of excessive menstrual bleeding. These circumstances lead to
the underdiagnosed cases and suboptimal treatment of women
with bleeding disorders, including unnecessary hysterectomy
(Ranson and John, 2002). In the US setting it has already been
proven that hysterectomy imposes a significant burden on the
national hospital sector (Easterday et al., 1983). Furthermore, it
is known that other major gynecological interventions such as
cesarean section are greatly overused and the major obstacle to
delivering universal health coverage nationwide (Gibbons et al.,
2010). It was even since the 1980s that elective hysterectomy was
disputed as an exemplary non-necessary surgical intervention
in many clinical cases (Travis, 1985). Economic consequences
of abnormal uterine bleeding attracted attention in academic
research even in more recent years (Liu et al., 2007). Overlooked
evidence in clinical interventions makes serious ramifications
in terms of excessive consumption of non-necessary medical
services and incurred additional costs of care (Palmer et al.,
1986). In most situations attending physician is unaware of
the existing evidence to guide his/her decision toward far less
risky pharmacological treatment of bleeding disorder (Chang
et al., 2003). Thus, such excessive surgery falls into the
so called “supplier induced demand” phenomenon (Labelle
et al., 1994). One of the possible approaches to tackle this
inefficiencymight be to invest into the capacity building and raise
clinicians’ consciousness about more cost-effective and less risky
procedures (Jakovljevic et al., 2016b).Among other solutions has
been proposed an alternative treatment strategy of deploying
levonorgestrel-releasing intrauterine system vs. hysterectomy for
treatment of menorrhagia (Hurskainen et al., 2001). In risky
pregnancies and many other associated conditions there is
documented evidence of significant inequality in incremental
cost-effectiveness ratios even among the standard gynecological
treatments (Jakovljevic et al., 2008). Such inequalities in ICERs
measured in a sound methodological framework indicate that
clinical physician’s should be more acquainted to deal with
health economic evidence. History of health economics taught
us that even minor niche for improvement in clinical decision
making could mean a lot for the social opportunity cost of
potentially misleading reasoning (Jakovljevic and Ogura, 2016).
This peculiar insight from the gynecology surgical practice
gives an excellent hints toward serious and hidden causes of
excessive demand for medical services. Opportunity costs of
lost opportunity for conventional treatment via pharmacological
protocols, here might mean incurring higher costs of medical
care in the short run (Jakovljevic et al., 2016c). However, potential
for long term savings is obvious. Particularly keeping in mind
that population aging is the cornerstone demographic landmark
of our time (Jakovljevic and Ogura, 2016). Preserving the fertility
choice for young women who might be willing and capable to
sustain at least one or one more child in their lifetime is precious.
It’s not only a blessing for the individual family. It is a blessing
for most modern day societies whose demographic dividends
have long forgone (Pandey, 2015). Medical decision crossroads
where such a deep choices depend on estimate and knowledge of
single attending physician should be given far more attention in
a foreseeable future.
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